Medical Director Eastern Region
Inova Heart and Vascular Institute, Inova Alexandria Hospital
Alexandria, Virginia
Presenter
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Panelist
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Presenter
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
Presenter
SESSION 96: VENOUS STENT TRIALS
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Do Statins Matter In The Treatment Of Patients With PE
10:30 AM - 10:40 AM
Panelist
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
11:35 AM - 12:00 PM
Presenter
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
6:58 AM - 7:03 AM
Presenter
SESSION 96: VENOUS STENT TRIALS
Zilver Vena Stent Trial: 4-Year Outcomes
8:59 AM - 9:04 AM
CONTROVERSIES IN VENOUS DISEASE MANAGEMENT
WEDNESDAY, NOVEMBER 20, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
10:45 AM - 10:50 AM
Low Dose Aspirin Is Adequate For Stented NIVLs
WEDNESDAY, NOVEMBER 20, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
10:45 AM - 10:50 AM
Low Dose Aspirin Is Adequate For Stented NIVLs